Latest Chemical pathology Stories

TAMPA, Fla., Jan. 8, 2013 /PRNewswire-iReach/ -- US HCG Injections is the USA's premier supplier of real pharmaceutical HCG at the best prices in North America. The products are made in a US based compounding pharmacy and a licensed physician is on hand to approve orders as they arrive. (Photo: http://photos.prnewswire.com/prnh/20130108/CG38997) A recent testimonial posted by US HCG Injections covers the amazing and inspiring weight loss story of Mike Alexander. Mr. Alexander...

HILDEN, Germany and GERMANTOWN, Maryland, January 7, 2013 /PRNewswire/ -- - QIAGEN invests in new companion diagnostic being developed by Drug Response Dx that aims to predict efficacy of TNF-alpha inhibitors in rheumatoid arthritis patients - Rights to RET, ROS1 and DEPDC1 biomarkers gained from Insight Genetics offer promise as companion diagnostics in lung cancer - New tests from Inserm for mutations of HSP110 gene...

Elevated levels of C-reactive protein, a marker of inflammatory disease, appear to be associated with increased risk of psychological distress and depression in the general population of adults in Denmark, according to a report published Online First by Archives of General Psychiatry, a JAMA Network publication. Depression is one of the leading causes of disability and previous studies suggest that low-grade systemic inflammation may contribute to the development of depression. C-reactive...

New market research report “Hospital-based Point of Care Diagnostics: Products, Players and Outlook to 2017” developed by Espicom Business Intelligence has been recently published by Market Publishers Ltd. According to the study, the market for POC diagnostic products used in a hospital setting was evaluated at about USD 3 billion in 2011. London, UK (PRWEB) December 14, 2012 The hospital-based point-of-care product (POC) sector showed a growth rate of over 7.3 percent in 2011. The...

ABBOTT PARK, Ill., Dec. 13, 2012 /PRNewswire/ -- Acute chest pain is one of the most common reasons people seek emergency care, and time is a critical factor in diagnosing and treating people who may be having a heart attack. The latest generation of diagnostic tests in development is expected to provide information that will be important to patient outcomes, potentially reducing the time to diagnosis of heart attacks by several hours. The specific performance characteristics of...

LONDON, Dec. 12, 2012 /PRNewswire/ -- Cardiovascular disease (CVD) is the main cause of death in the EU, killing over 2 million people annually and costing the economy nearly EUR192 billion. Prevention, through constant monitoring of heart health, is seen as the best way to tackle this high death rate. The most accurate way of monitoring heart health is through cardiac marker testing. Regular monitoring of cardiac health through brain natriuretic peptide (BNP) testing is being...

TEL AVIV, Israel, December 10, 2012 /PRNewswire/ -- NeuroQuest [http://www.neuro-quest.com ], a company of the Trendlines Group's Misgav Venture Accelerator is moving quickly towards an important validation trial for novel blood-based immune biomarkers for the diagnosis of Alzheimer's disease. The company's biomarker platform for neurodegenerative diseases is based on the research of Prof. Michal Schwartz, Chair of Neuroimmunology at the Weizmann Institute of Science who...

Husband, father and hcg diet participant tells US HCG Injections about his forty pounds of weight loss in just one month. Largo, FL (PRWEB) December 09, 2012 A recent testimonial posted by US HCG Injections covers the amazing and inspiring weight loss story of Mike Alexander. Mr. Alexander is a husband and father as well as a former athlete in high school having participated in one of the most grueling sports on the planet, high school wrestling. Unfortunately, in 2010 Mr. Alexander...

LAUSANNE, Switzerland, December 5, 2012 /PRNewswire/ -- Biocartis launches its revolutionary detection platform, Dynamic Multi-Analyte Technology ("DMAT"): - New proteomic and nucleic acid platform provides ultra-high quality data analysis even at higher multiplex formats. - Platform launched well ahead of plan. Biocartis flips from a late-stage development company into a commercial business. Accurate and fast validation...

BOSTON, Dec. 4, 2012 /PRNewswire-USNewswire/ -- Boston Children's Hospital announced today that it will receive a $1.7M grant through the Biomarkers of Gut Function and Health program within the Grand Challenges in Global Health initiative. This initiative was launched by the Bill & Melinda Gates Foundation to overcome persistent bottlenecks preventing the creation of new and better health solutions for the developing world. Christopher Duggan, MD, MPH , director of Boston...